Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

Université Laval

$117,826.00

Next Generation Treatment Planning Algorithms for Brachytherapy

EF 2024-25

Résumé
This collaborative research focuses on enhancing brachytherapy, a cancer treatment where radiation sources are placed close to or inside the tumor. Brachytherapy uses radioactive isotopes to deliver high doses of radiation directly to cancer cells while efficiently sparing surrounding healthy tissue. In partnership with a world-leading brachytherapy equipment manufacturer, this proposal aims to leverage our expertise in novel, ultrafast multi-criteria optimization (gMCO). We will use gMCO as a foundational tool to develop and validate the next generation of planning algorithms, extending its applications beyond those documented in the literature. These algorithms are expected to pioneer advanced, efficient therapeutic strategies for cancer care, particularly through brachytherapy. Elekta views gMCO as a vital component in the development of current and future product lines. This initiative will explore broadening gMCO's capability with various brachytherapy tools and applicators, especially for GYN brachytherapy. Additionally, we propose using gMCO as a base to explore advanced brachytherapy planning approaches, such as radiobiological optimization and the role of artificial intelligence in multicriteria treatment planning. We further aim to demonstrate the feasibility of real-time multi-criteria robust planning by leveraging gMCO's optimization speed. Our long-term objective is to provide Elekta with actionable solutions that enhance gMCO's clinical value, leading to more efficient cancer treatments and ensuring Canada has access to a much needed highly trained workforce.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
597548-2024
Name nom
Beaulieu, Luc L
Department département
Physique, génie physique et optique
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
117826
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3115
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Medical Physics
Research subject fr
Physique médicale
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Next Generation Treatment Planning Algorithms for Brachytherapy
Keywords
biomedical engineering; brachytherapy; cancer; medical devices; medical physics; multi-criteria optimization; optimization algorithms; radiation oncology; radiation physics; treatment planning
Application summary
This collaborative research focuses on enhancing brachytherapy, a cancer treatment where radiation sources are placed close to or inside the tumor. Brachytherapy uses radioactive isotopes to deliver high doses of radiation directly to cancer cells while efficiently sparing surrounding healthy tissue. In partnership with a world-leading brachytherapy equipment manufacturer, this proposal aims to leverage our expertise in novel, ultrafast multi-criteria optimization (gMCO). We will use gMCO as a foundational tool to develop and validate the next generation of planning algorithms, extending its applications beyond those documented in the literature. These algorithms are expected to pioneer advanced, efficient therapeutic strategies for cancer care, particularly through brachytherapy. Elekta views gMCO as a vital component in the development of current and future product lines. This initiative will explore broadening gMCO's capability with various brachytherapy tools and applicators, especially for GYN brachytherapy. Additionally, we propose using gMCO as a base to explore advanced brachytherapy planning approaches, such as radiobiological optimization and the role of artificial intelligence in multicriteria treatment planning. We further aim to demonstrate the feasibility of real-time multi-criteria robust planning by leveraging gMCO's optimization speed. Our long-term objective is to provide Elekta with actionable solutions that enhance gMCO's clinical value, leading to more efficient cancer treatments and ensuring Canada has access to a much needed highly trained workforce.